SEC Form 3
FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 08/02/2016 | 3. Issuer Name and Ticker or Trading Symbol SYMANTEC CORP [ SYMC ] | |||||||||||||
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 104,046(1) | D | |
Common Stock | 128,612(2) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (3) | 01/27/2026 | Common Stock | 1,482,183 | (4) | D |
Explanation of Responses: |
1. Shares acquired pursuant to the merger (the "Merger") in which a wholly owned subsidiary of Symantec Corporation ("Symantec") was merged with and into Blue Coat, Inc. ("Blue Coat"). The Reporting Person held 59,219.77 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest 30% on August 1, 2017, 30% on August 1, 2018, and 40% on August 1, 2019. |
2. Shares acquired pursuant to the Merger. The Reporting Person held 73,202.22 restricted stock units to acquire Blue Coat common stock that were exchanged for restricted stock units to acquire Symantec common stock in the Merger. On the effective date of the Merger, the closing price of Symantec's common stock was $20.55 per share. Shares to vest in equal quarterly installments from August 1, 2016 over a period of approximately two years, ending June 1, 2018. |
3. 370,445 options are fully vested as of August 1, 2016. The remaining options vest and become exercisable in equal monthly installments over a period of two years, beginning August 1, 2016. |
4. Acquired pursuant to the Merger. The Reporting Person held an employee stock option to acquire 997,000 shares of Blue Coat common stock for $12.40 per share that was exchanged for this option to purchase shares of common stock of Symantec in the Merger. |
Remarks: |
/s/ Philip Reuther, as attorney-in-fact for Nicholas R. Noviello | 08/11/2016 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |